Efficacy and safety of triplet regimen capecitabine, oxaliplatin, and irinotecan (XELOXIRI) as first-line chemotherapy for advanced pancreatic cancer by Bi-Yang Cao, Qi Cao, Xiao-Ting Ma, Kai Ou, Wen-Wei Yang, Le-Tian Zhang, Jing-Yu Lu, Zhi-Chao Jiang, Wen Zhang, Jie Zhang, Qi Wang, Li-Zhen Gao, Lin Yang

Get full text